![Al Robichaud](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Al Robichaud
Private Equity Investor bei
Cure Ventures Management LP
Profil
Derzeit ist Albert J. Robichaud Chief Scientific Officer von SAGE Therapeutics, Inc. Dr. Robichaud war zuvor als VP-Chemistry & Pharmacokinetic Sciences bei Lundbeck USA Inc. und als Senior Director & Head-Neuroscience Discovery bei Wyeth Research tätig. Albert J. Robichaud erwarb einen Bachelor-Abschluss am Rensselaer Polytechnic Institute und einen Doktortitel an der University of California, Irvine.
Aktive Positionen von Al Robichaud
| Unternehmen | Position | Beginn |
|---|---|---|
Cure Ventures Management LP
 Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments. | Private Equity Investor | 01.01.2024 |
Ehemalige bekannte Positionen von Al Robichaud
| Unternehmen | Position | Ende |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 09.10.2023 |
Lundbeck, Inc.
 Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Corporate Officer/Principal | 01.01.2011 |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Discovers and develops platforms encompassing pharmaceuticals | Direktor/Vorstandsmitglied | 01.01.2010 |
Lundbeck USA Inc. | Corporate Officer/Principal | - |
Ausbildung von Al Robichaud
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
32
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Discovers and develops platforms encompassing pharmaceuticals | Commercial Services |
Lundbeck, Inc.
Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Health Technology |
Lundbeck USA Inc. | |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Cure Ventures Management LP
Cure Ventures Management LP Investment ManagersFinance Cure Ventures invests in companies located in the United States. The firm targets companies operating in the fields of life science and biotechnology sectors. It provides financing for seed and early stage capital requirements. It acts as a lead investor and also makes follow-on investments. | Finance |
